Literature DB >> 15168227

Factors influencing seizures in adult patients with supratentorial astrocytic tumors.

S-L Hwang1, C-L Lin, K-S Lee, A-S Lieu, T-H Kuo, C-Z Chang, C-P Yen, C-K Lin, J-K Loh, T-Y Huang, S-L Howng.   

Abstract

Seizures and epilepsy in adults are important and increasingly common clinical problems. Despite this, the investigation of seizures in adults with astrocytic tumors remains a grey area. The incidence and influencing factors of preoperative and postoperative seizures were evaluated in 101 patients of 45 years or older with supratentorial astrocytic tumors. Preoperative seizures occurred in 14 (14%) patients. Seizures at presentation were significantly correlated with pathological grades of astrocytic tumors (p = 0.0318). The risk of seizures at presentation was greatest in patients with well-differentiated astrocytomas as compared with anaplastic astrocytomas (Odds ratio = 4.364, p = 0.056) or glioblastomas multiforme (Odds ratio = 5.673, p = 0.007). There was no association of preoperative seizures with age, sex, location or site of the tumors. Postoperative seizures occurred in 18 (18%) patients, including 8 (8/14, 57%) recurrent seizures and 10 (10/87, 12%) late-onset seizures. Postoperative seizures were significantly correlated with the presence of preoperative seizures (p = 0.0003). The presence of preoperative seizures was potentially predictive of postoperative seizures when evaluated by logistic regression model (Odds ratio = 6.650). Thirteen (72%) of 18 patients with postoperative seizures were associated with tumor recurrence in 7 cases, hemorrhage in 3 cases and malignant progression in 3 cases. There was no association of postoperative seizures with age, sex, location or site of the tumors, grades of tumors, type of preoperative seizures, duration of preoperative seizures, serum level of anticonvulsant drug, extent of surgery, postoperative radiation or chemotherapy. The patients with preoperative seizures had a higher risk of postoperative seizures and should be carefully monitored. Imaging examination of brain to exclude the possibilities of tumor recurrence or hemorrhage is warrantable in supratentorial astrocytoma patients with postoperative seizures. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Year:  2004        PMID: 15168227     DOI: 10.1007/s00701-004-0266-8

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  15 in total

Review 1.  Treatment of epileptic seizures in brain tumors: a critical review.

Authors:  R Bauer; M Ortler; M Seiz-Rosenhagen; R Maier; J V Anton; I Unterberger
Journal:  Neurosurg Rev       Date:  2014-04-24       Impact factor: 3.042

2.  Peri-ictal pseudoprogression in patients with brain tumor.

Authors:  Sylvain Rheims; Damien Ricard; Martin van den Bent; Luc Taillandier; Véronique Bourg; Virginie Désestret; Stéphanie Cartalat-Carel; Marc Hermier; Annick Monjour; Jean-Yves Delattre; Marc Sanson; Jérôme Honnorat; François Ducray
Journal:  Neuro Oncol       Date:  2011-07       Impact factor: 12.300

3.  Non-convulsive status epilepticus in brain tumors.

Authors:  M Casazza; I Gilioli
Journal:  Neurol Sci       Date:  2011-11       Impact factor: 3.307

4.  Morphological characteristics of brain tumors causing seizures.

Authors:  Jong Woo Lee; Patrick Y Wen; Shelley Hurwitz; Peter Black; Santosh Kesari; Jan Drappatz; Alexandra J Golby; William M Wells; Simon K Warfield; Ron Kikinis; Edward B Bromfield
Journal:  Arch Neurol       Date:  2010-03

Review 5.  Antiepileptic therapy in patients with central nervous system malignancies.

Authors:  Glen H J Stevens
Journal:  Curr Neurol Neurosci Rep       Date:  2006-07       Impact factor: 5.081

Review 6.  [Primary brain tumors and brain metastases. Symptomatic epilepsy and driving ability - systematic review and expert opinion].

Authors:  P S Reif; A Strzelczyk; S Rüegg; A H Jacobs; A Haag; A Hermsen; U Sure; S Knake; H M Hamer; H Strik; G Krämer; R Engenhart-Cabilic; F Rosenow
Journal:  Nervenarzt       Date:  2010-12       Impact factor: 1.214

7.  Increasing Seizure Activity During Radiation Treatment for High-grade Gliomas - Final Results of a Prospective Interventional Study.

Authors:  Dirk Rades; Jaspar Witteler; Peter Trillenberg; Denise Olbrich; Steven E Schild; Søren Tvilsted; Troels W Kjaer
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

8.  Seizures during the management of high-grade gliomas: clinical relevance to disease progression.

Authors:  Young-Hoon Kim; Chul-Kee Park; Tae Min Kim; Seung Hong Choi; Yu Jung Kim; Byung Se Choi; Jung Ho Han; Se-Hoon Lee; Chae-Yong Kim; In Ah Kim; Dae Seog Heo; Il Han Kim; Dong Gyu Kim; Hee-Won Jung
Journal:  J Neurooncol       Date:  2013-03-04       Impact factor: 4.130

Review 9.  Incidental diffuse low-grade gliomas: from early detection to preventive neuro-oncological surgery.

Authors:  Guilherme Lucas de Oliveira Lima; Marc Zanello; Emmanuel Mandonnet; Luc Taillandier; Johan Pallud; Hugues Duffau
Journal:  Neurosurg Rev       Date:  2015-11-27       Impact factor: 3.042

10.  Outcome and tolerability of topiramate in brain tumor associated epilepsy.

Authors:  M Maschio; L Dinapoli; A Zarabla; A Pompili; C M Carapella; A Pace; D Giannarelli; E Occhipinti; B Jandolo
Journal:  J Neurooncol       Date:  2007-06-28       Impact factor: 4.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.